Episode 25015
Beyond Pills and Shots... Sean Ainsworth, CEO, Immusoft
BioTech Nation ... with Dr. Moira Gunn · Moira Gunn
April 16, 202512m 44s
Audio is streamed directly from the publisher (media.transistor.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
This week on BioTech Nation, Sean Ainsworth, CEO of ImmuSoft, explains how modifying the body’s own B cells to produce therapeutic proteins could revolutionize drug delivery. From improving treatment for rare diseases like Hurler syndrome to potentially replacing injections for autoimmune and metabolic conditions, this new approach opens the door to long-term, patient-specific solutions.
Topics
B cellsgene therapydrug deliverychronic diseaseHurler syndrometherapeutic proteinsImmuSoftSean AinsworthbiotechGLP-1autoimmune diseasecell therapyrare diseaseprotein productionBioTech Nation